{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:32:55Z","timestamp":1758817975065},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1992]]},"DOI":"10.1007\/bf00686943","type":"journal-article","created":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T06:05:39Z","timestamp":1101881139000},"page":"S55-S58","source":"Crossref","is-referenced-by-count":2,"title":["Results of adjuvant chemotherapy for invasive uroepithelial cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Yasunari","family":"Uekado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuyuki","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Shinka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0090-4295(84)80080-1","volume":"23","author":"AB Einstein","year":"1984","unstructured":"Einstein AB, Shipley W, Coombs J, Cummings KB, Soloway MS, Hawkins I (1984) Cisplatin as adjunctive treatment for invasive bladder carcinoma: tolerance and toxicities. Urology 23: 110","journal-title":"Urology"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0022-5347(17)55143-5","volume":"125","author":"NM Heney","year":"1981","unstructured":"Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC (1981) Prognostic factors in carcinoma of the ureter. J Urol 125: 632","journal-title":"J Urol"},{"issue":"Suppl 2","key":"CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0090-4295(85)90527-8","volume":"25","author":"HW Herr","year":"1985","unstructured":"Herr HW (1985) Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology 25 [Suppl 2]: 127","journal-title":"Urology"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0090-4295(85)90532-1","volume":"25","author":"DE Hill","year":"1985","unstructured":"Hill DE, Ford KS, Soloway MS (1985) Radical cystectomy and adjuvant chemotherapy. Urology 25: 151","journal-title":"Urology"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-5347(17)52202-8","volume":"129","author":"G Jakse","year":"1983","unstructured":"Jakse G, Frommhold H, Marberger H (1983) Combined cisplatin and radiation therapy in patients with stages pT3 and pT4 bladder cancer: a pilot study. J Urol 129: 502","journal-title":"J Urol"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19900115)65:2<207::AID-CNCR2820650204>3.0.CO;2-2","volume":"65","author":"RJ Miller","year":"1990","unstructured":"Miller RJ, Bahnson RR, Banner B, Ernstoff MS, O'Donnell W (1990) Neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin for locally advanced transitional cell carcinoma of the bladder. Cancer 65: 207","journal-title":"Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0090-4295(82)90601-X","volume":"19","author":"BN Nocks","year":"1982","unstructured":"Nocks BN, Perrone TA, Heney NM, Griffin PP, Daly JJ, Prout GR Jr (1982) Transitional cell carcinoma of renal pelvis. Urology 19: 472","journal-title":"Urology"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-5347(17)50459-0","volume":"131","author":"RTD Oliver","year":"1984","unstructured":"Oliver RTD, England HR, Risdon RA, Blandy JP (1984) Methotrexate in the treatment of metastatic and recurrent primary transitional cell carcinoma. J Urol 131: 483","journal-title":"J Urol"},{"key":"CR9","first-page":"2838","volume":"37","author":"DG Skinner","year":"1977","unstructured":"Skinner DG (1977) Current state of classification and staging of bladder cancer. Cancer Res 37: 2838","journal-title":"Cancer Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0022-5347(17)50809-5","volume":"131","author":"DG Skinner","year":"1984","unstructured":"Skinner DG, Lieskovsky G (1984) Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol 131: 1069","journal-title":"J Urol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-5347(17)48996-8","volume":"133","author":"CN Sternberg","year":"1985","unstructured":"Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Whitmore WF (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. J Urol 133: 403","journal-title":"J Urol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/1097-0142(19891215)64:12<2448::AID-CNCR2820641209>3.0.CO;2-7","volume":"64","author":"CN Sternberg","year":"1989","unstructured":"Sternberg CN, Yagoda A, Scher HI, Watson RC, Geller N, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Weiselberg L, Rosado K, Smart T, Lin S, Penenberg D, Fair W, Whitmore WF (1989) Methotrexate, vinblastine, doxorubicin and cisplatin for advanced transitional cell\u00b7carcinoma of the urothelium. Cancer 64: 2448","journal-title":"Cancer"},{"issue":"Suppl","key":"CR13","first-page":"24","volume":"20","author":"Y Uekado","year":"1987","unstructured":"Uekado Y, Shinka T, Hirano A, Ohkawa T (1987) Adjuvant chemotherapy for invasive bladder cancer. Cancer Chemother Pharmacol 20 [Suppl]: S24","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR14","first-page":"1565","volume":"63","author":"A Yagoda","year":"1979","unstructured":"Yagoda A (1979) Phase II trials withcis-dichlorodiammineplatinum(II) in the treatment of urological cancer. Cancer Treat Rep 63: 1565","journal-title":"Cancer Treat Rep"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686943.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686943\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,5]],"date-time":"2019-04-05T06:11:09Z","timestamp":1554444669000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992]]},"references-count":14,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1992]]}},"alternative-id":["BF00686943"],"URL":"https:\/\/doi.org\/10.1007\/bf00686943","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992]]}}}